Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...

City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...

In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the CEPHEUS, IMROZ, and BENEFIT trials of treatment for transplant-ineligible ...

Individual paraproteinemic disorders exhibit distinct neuropathic phenotypes, often with characteristic, identifiable clinical features. Frequently, prognoses are not well-defined, and in many ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

Saad Usmani, Chief of MSK's Myeloma Service, says there are far more treatment options for multiple myeloma today compared with just 20 years ago. Note: This story was originally published in 2022 and ...

A 54-year-old woman with IgG kappa multiple myeloma (diagnosed in November 2019) and a high-risk cytogenetic profile (t[4;14] and gain[1q]) had received frontline therapy with bortezomib ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. Meanwhile, some people can have a series of less intense ...

An Icelandic family with multiple cases of MGUS, WM, and lymphoma was first described in 1978. In vitro testing of peripheral blood lymphocytes revealed increased production of immunoglobulins in ...